Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 193, Issue 9, Pages 1087-1096Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.193.9.1087
Keywords
asthma; cytokines; eosinophil; transcription factor; knockout mouse
Categories
Funding
- NHLBI NIH HHS [F32-HL10375-01] Funding Source: Medline
- NIAID NIH HHS [R01-AI40618] Funding Source: Medline
Ask authors/readers for more resources
Antigen-specific CD4 T helper type 2 (Th2) cells play a pivotal role in the induction of allergic asthma, but the mechanisms regulating their recruitment into the airways are unknown. Signal transducer and activator of transcription factor (Stat)6 is a transcription factor essential for Th2 cell differentiation. Here we show that Stat6 also controls Th2 cell recruitment and effector function in allergic inflammation in vivo. To isolate the role of Stat6 in regulating Th2 cell trafficking and effector function from its role in Th2 cell differentiation, we used a murine model of asthma in which in vitro-differentiated Stat6(+/+) antigen-specific Th2 cells were adoptively transferred into naive Stat6(-/-) and Stat6(+/+) mice followed by aerosol antigen challenge. We found that all of the features of asthma, including Th2 cell accumulation, Th2 and eosinophil-active chemokine production, and airway eosinophilia, mucus production, and hyperresponsiveness seen in Stat6(+/+) mice, were dramatically absent in Stat6(-/-) mice that received Stat6(+/+) antigen-specific Th2 cells. Our findings establish Stat6 as essential for the Th2 cell trafficking and effector function and suggest that interruption of Stat6 signaling in resident cells of the lung is a novel approach to asthma therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available